1

2
Kwangho Lee, Deqiang Niu, Matthew F Baevsky: Mutant-selective EGFR inhibitors and uses thereof. Celgene Avilomics Research, Choate Hall & Stewart, Charles E Lyon, Kristen C Buteau, August 9, 2016: US09409887 (3 worldwide citation)

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.


3

4
Kwangho Lee, Deqiang Niu, Matthew F Baevsky: Mutant-selective egfr inhibitors and uses thereof. Avila Therapeutics, June 21, 2012: US20120157426-A1

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.


5
MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF. January 22, 2015: US20150025055-A1

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.


6
MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF. November 17, 2016: US20160332994-A1

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.